PLX7486 TsOH: Clinical Trials

1 trial of PLX7486 TsOH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow PLX7486 TsOH: new trials by email Literature Review of PLX7486 TsOH trials Research Report on PLX7486 TsOH

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
PLX7486 TsOH - Solid Tumor, Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations
Phase 1TerminatedPlexxikon592013-08-012018-08-02

Conditions studied

Giant Cell Tumor of Tendon Sheath (1)

Sponsors

Plexxikon (1)

Countries

United States (1)